Test could measure patient immunity against multiple COVID-19 variants such as Omicron and Delta at once and inform which synthetic monoclonal antibody to use for treatments.
Duke CAGPM members, Jack Anderson, Anna Mazur, Tom Burke, and Chris Woods all contributing to the study.